Learn About the Science of Intravascular Lithotripsy

Recent Advances in Intravascular Lithotripsy (IVL) are Paving the Way for More Effective Treatment of Artery Calcification

Understanding the Reimbursement Landscape for Coronary and Peripheral Intravascular Lithotripsy (IVL) Procedures

Frequently Asked Questions about Intravascular Lithotripsy (IVL)

How Does Intravascular Lithotripsy (IVL) Work?

The Economics of Arterial Disease: Costs and Market Size for CAD and PAD

The Leading Intravascular Lithotripsy (IVL) Companies and Products: Shockwave, FastWave, and the Future of CAD and PAD Treatment

When to Use Intravascular Lithotripsy (IVL): Indications and Applications

This is What Happens During an Intravascular Lithotripsy (IVL) Procedure for Artery Calcification

Intravascular Lithotripsy (IVL) Procedures Have an Excellent Safety Profile With Minimal Complications

Treatments for Artery Calcification Include Medications and Interventions like Angioplasty and Intravascular Lithotripsy (IVL)

How Cholesterol and Plaque Buildup Lead to Artery Diseases Like CAD and PAD

Intravascular Lithotripsy (IVL) Glossary

Unlocking Calcified Arteries and Treating CAD and PAD with Intravascular Lithotripsy (IVL)

Invest in the Future of IVL

We oversubscribed our last round of financing in just a few weeks, so don’t miss out on the next opportunity to invest.

Learn More

$40M+ raised from corporate venture, VC, and KOLs.

Successful peripheral and coronary FIH procedures.

Only market incumbent acquired in 2024 by J&J for $13B.

8 patents granted by the USPTO and multiple FTOs.

Invest in the Future of IVL

We oversubscribed our last round of financing in just a few weeks, so don’t miss out on the next opportunity to invest.

Learn More

$40M+ raised from corporate venture, VC, and KOLs.

Successful peripheral and coronary FIH procedures.

Only market incumbent acquired in 2024 by J&J for $13B.

8 patents granted by the USPTO and multiple FTOs.

Invest in the Future of IVL

We oversubscribed our last round of financing in just a few weeks, so don’t miss out on the next opportunity to invest.

Learn More

$40M+ raised from corporate venture, VC, and KOLs.

Successful peripheral and coronary FIH procedures.

Only market incumbent acquired in 2024 by J&J for $13B.

8 patents granted by the USPTO and multiple FTOs.

Invest in the Future of IVL

We oversubscribed our last round of financing in just a few weeks, so don’t miss out on the next opportunity to invest.

Learn More

$40M+ raised from corporate venture, VC, and KOLs.

Successful peripheral and coronary FIH procedures.

Only market incumbent acquired in 2024 by J&J for $13B.

8 patents granted by the USPTO and multiple FTOs.

Follow FastWave's Journey

Next-level intravascular lithotripsy (IVL) devices for calcific artery disease.

FastWave Medical is developing devices limited by Federal (or United States) law to investigational use. To see FastWave’s patents, click here.

Follow FastWave's Journey

Next-level intravascular lithotripsy (IVL) devices for calcific artery disease.

FastWave Medical is developing devices limited by Federal (or United States) law to investigational use. To see FastWave’s patents, click here.

Follow FastWave's Journey

Next-level intravascular lithotripsy (IVL) devices for calcific artery disease.

FastWave Medical is developing devices limited by Federal (or United States) law to investigational use. To see FastWave’s patents, click here.

Follow FastWave's Journey

Next-level intravascular lithotripsy (IVL) devices for calcific artery disease.

FastWave Medical is developing devices limited by Federal (or United States) law to investigational use. To see FastWave’s patents, click here.